Skip to content

Clinical study of early donepezil combined with rTMS / tDCS in the treatment of severe TBI cognitive impairment

Clinical study of early donepezil combined with rTMS / tDCS in the treatment of severe TBI cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059260
Enrollment
Unknown
Registered
2022-04-27
Start date
2022-05-10
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury

Interventions

Transcranial magnetic stimulation combined with donepezil group:Transcranial magnetic stimulation combined with donepezil
Transcranial direct current stimulation combined with donepezil group:Transcranial direct current stimulation combined with donepezil

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-60 years; 2. Meet the diagnostic criteria of brain injury in Modern Neurosurgery (Second Edition) in 2015, that is, have a clear history of brain injury; 3. Those with intracranial hemorrhage or brain contusion confirmed by CT or MRI, and the clinical diagnosis result is severe brain injury; 4. The patient with closed craniocerebral injury whose course of disease is less than 3 months is stable; 5. Patients with clear mind and no aphasia who can cooperate independently to complete treatment and evaluation; 6. There is clear cognitive impairment after brain injury, and there is no cognitive impairment before injury; 7. The family members or patients agreed and signed the informed consent after being informed of the condition in detail.

Exclusion criteria

Exclusion criteria: 1. Patients with worsening condition and new cerebral infarction and cerebral hemorrhage; 2. People with epilepsy, serious heart and lung disease, malignant tumor and psychiatric history; 3. Patients with aphasia and comprehension disorders at the same time; 4. There are metal implants in the body, such as cardiac pacemaker or cochlear implant, or there are implanted materials in the brain (such as deep brain electrode, ventriculo-peritoneal shunt, aneurysm clip); 5. Patients with contraindication of hyperbaric oxygen, patients with drug allergy to olactam and donepezil; 6. Patients who are unwilling or unable to complete the Montreal cognitive assessment (MOCA).

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA);Minimum Mental State Examination(MMSE);

Secondary

MeasureTime frame
Modified Barthel index rating scale(MBI);

Countries

China

Contacts

Public ContactYumei Ma

Lanzhou University Second Hospital

675152359@qq.com+86 18709404311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026